The risk of a biosimilar void in Europe by Giuliana Miglierini The undergoing revision of the pharmaceutical legislation aims, among others, to redefine data protection to…
A new joint work plan to 2023 for EMA and EUnetHTA 21 by Giuliana Miglierini The new Regulation (EU) 2021/228 on Health Technology Assessment (HTA) will assume full validity in…